Weight-loss jabs could ‘slow down the clock’ on biological ageing

Weight-loss injections could “slow down the clock” on biological ageing as they treat the underlying cause of a range of diseases, experts have suggested.

More than ten studies were presented at the European Society of Cardiology conference on Friday showing that semaglutide, also known as Ozempic or Wegovy, has ”far-reaching benefits beyond what we initially imagined”.

The drug was found to cut levels of inflammation in the body regardless of whether or not people lost weight.